{
    "id": "ff299226-ff10-4316-9dfe-377c12723b6f",
    "indications": {
        "text": "metoprolol succinate extended-release tablets , beta-adrenergic blocker indicated treatment : hypertension , lower blood pressure . lowering blood pressure reduces risk fatal non-fatal cardiovascular events , primarily strokes myocardial infarctions . ( 1.1 ) angina pectoris . ( 1.2 ) heart failure , reduce risk cardiovascular mortality heart failure hospitalizations patients heart failure ( 1.3 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "administer daily . titrate weekly longer intervals needed tolerated . ( 2 ) hypertension : starting dose 25 100 mg. ( 2.1 ) angina pectoris : starting dose 100 mg. ( 2.2 ) heart failure : starting dose 12.5 25 mg. ( 2.3 ) switching immediate-release metoprolol metoprolol succinate extended-release tablets : total daily dose metoprolol succinate extended-release tablets . ( 2 )",
        "doid_entities": [
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "product : 50090-5418 ndc : 50090-5418-0 30 tablet , extended release bottle ndc : 50090-5418-1 90 tablet , extended release bottle",
    "adverseReactions": "known hypersensitivity product components . ( 4 ) severe bradycardia : greater first degree heart block , sick sinus syndrome without pacemaker . ( 4 ) cardiogenic shock decompensated heart failure . ( 4 )",
    "ingredients": [
        {
            "name": "METOPROLOL SUCCINATE",
            "code": "TH25PD4CCB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6905"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "ETHYLCELLULOSE (10 MPA.S)",
            "code": "3DYK7UYZ62",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11228"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        },
        {
            "name": "HYDROXYPROPYL METHYLCELLULOSE",
            "code": "3NXW29V3WO",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30618"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "METHYLCELLULOSE (15 CPS)",
            "code": "NPU9M2E6L8",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11228"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        },
        {
            "name": "SAND",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32178"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        }
    ],
    "organization": "A-S Medication Solutions",
    "name": "metoprolol succinate",
    "effectiveTime": "20250521",
    "indications_original": "Metoprolol succinate extended-release tablets, are a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood      pressure reduces the risk of fatal and non-fatal cardiovascular events,      primarily strokes and myocardial infarctions. (1.1) Angina Pectoris. (1.2) Heart Failure, to reduce the risk of      cardiovascular mortality and heart failure hospitalizations in patients with heart      failure (1.3)",
    "contraindications_original": "Administer once daily. Titrate at weekly or longer      intervals as needed and tolerated. (2) Hypertension: Starting dose is 25 to 100 mg. (2.1) Angina Pectoris: Starting dose is 100 mg. (2.2) Heart Failure: Starting dose is 12.5 or 25 mg. (2.3) Switching from immediate-release metoprolol to      metoprolol succinate extended-release tablets: use the same total daily      dose of metoprolol succinate extended-release tablets. (2)",
    "warningsAndPrecautions_original": "Product:    50090-5418\n                  NDC:    50090-5418-0   30 TABLET, EXTENDED RELEASE in a BOTTLE\n                  NDC:    50090-5418-1   90 TABLET, EXTENDED RELEASE in a BOTTLE",
    "adverseReactions_original": "Known hypersensitivity to product components. (4) Severe bradycardia: Greater than first degree heart block, or sick sinus syndrome without a pacemaker. (4) Cardiogenic shock or decompensated heart failure. (4)",
    "drug": [
        {
            "name": "metoprolol succinate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6905"
        }
    ]
}